MedTrace Logo

SMS Reminder to Assess Adherence

NCT01308476 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 95

Last updated 2013-01-18

Study results available
· View outcomes & findings →

Summary

6 months open label non-interventional observational study acc to § 4, section 23 and § 67, section 6 German Medicines Act with two parallel groups

1. the SMS group receiving a daily SMS - a reminder to inhale Spiriva® 18 Microgram
2. the control group not receiving a daily SMS reminder

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

PROCEDURE

SMS reminder

daily SMS in the SMS group to remind of treatment with tiotropium

PROCEDURE

control group

no daily SMS to remind of treatment with tiotropium

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01308476 on ClinicalTrials.gov